Comparative Efficacy, Safety, and Cost‐Utility of DPP‐4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real‐World Clinical and Economic Outcomes.
Saved in:
| Title: | Comparative Efficacy, Safety, and Cost‐Utility of DPP‐4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real‐World Clinical and Economic Outcomes. |
|---|---|
| Authors: | Jimoh, Abdulgafar Olayiwola1 (AUTHOR) jimoh.abdulgafar@udusok.edu.ng, Hudu, Shuaibu Abdullahi2,3 (AUTHOR), Sabir, Anas Ahmad4,5 (AUTHOR), Adamu, Adamu Ahmed1 (AUTHOR), Bello, Nura1,6 (AUTHOR), Tahir, Albashir1,7 (AUTHOR), Abubakar, Nura1,8 (AUTHOR), Cui, Huantian (AUTHOR) richard.bright@flinders.edu.au |
| Source: | Journal of Diabetes Research. 4/2/2026, Vol. 2026, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23146745 |
|---|---|
| DOI: | 10.1155/jdr/8464330 |
